Page 16 - Sanket Koul

Drug regulator begins pan-Indian inspection of cough syrup makers

No state has fully complied with Corrective and Preventive Action (CAPA) guidelines, introduced for ensuring safety and maintaining standards in pharma products

Delhi HC dismisses Roche's plea, allows Natco to sell generic Risdiplam

A division bench comprising Justices C Hari Shankar and Ajay Digpaul upheld a March 2025 single-judge bench order that had denied Roche an injunction

Coventry University in talks with Edu Ministry for more India campuses

The UK-based university, which got approval for its first Indian campus in Gujarat's Gift City, plans further expansion under India's National Education Policy 2020

Punjab bans Coldrif, even as PIL in SC seeks probe on cough syrup deaths

With this, the state joins Maharashtra, Kerala and Tamil Nadu, who have already announced bans on the cough syrup

Eli Lilly's Mounjaro logs ₹80 crore in September, India's No. 2 drug

The highest-selling drug for the month was GlaxoSmithKline's Augmentin, an antibiotic, garnering revenues of ₹85 crore

Eli Lilly to pump $1 billion into India to boost contract manufacturing

The US pharma major to set up a manufacturing and supply hub in Hyderabad as part of a $1 billion investment aimed at boosting contract production in India

Realty's next address: NCR's growth arteries pulse via SPR, Sohna

Part-I of this three-part series dives into Delhi-NCR's SPR, Sohna, Dwarka Expressway, and Jewar Airport leading the charge

Cough syrup deaths: NHRC sends notices to MP, Rajasthan, Uttar Pradesh

NHRC issues notices to MP, Rajasthan and UP, asks states to probe children's deaths from alleged use of contaminated cough syrups

University of Western Australia aims to open India campuses by Aug 2026

Starting with an initial cohort of around 100 to 150 students, Littlefair said that UWA would particularly focus on business and science, technology, engineering, and mathematics (STEM) courses

Jan Aushadhi retailers ask govt to review minimum distance policy

Retailers say proximity of new outlets is hurting sales and seek higher trade margins along with GST loss compensation under the Jan Aushadhi scheme

Festival frenzy: Housing market sees room for growth after 3-quarter lull

Developers roll out slew of freebies, incentives to potential buyers

Health Secy reviews GMP norms with states after cough syrup deaths

Union Health Secretary Punya Salila Srivastava chaired a meeting with states after 11 children died in MP and Rajasthan, stressing strict GMP compliance and rational use of cough syrups in children

Centre revises rate structure for nearly 2,000 medical procedures

CGHS hospitals must accept new rates by Oct 13

MP children deaths: Contaminant found in cough syrup made by TN firm

Contaminant found in Coldrif cough syrup; risk-based investigations started at manufacturing sites of around 19 drugs sampled across 6 states

After 7 years, IHH finally gets Sebi go-ahead for Fortis open offer

In 2018, price was set at ₹170/share; Fortis Healthcare now trades at ₹980.10

Govt warns against cough syrup use in kids after 11 deaths in MP, Rajasthan

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan, though tests found no contamination in samples

IPA appoints Zydus Lifesciences MD Sharvil Patel as new President

Sharvil Patel takes over as President of IPA from Samir Mehta, with Glenn Saldanha appointed Vice President, as the industry navigates reforms and global challenges

Retail REITs set to grow as institutional investors back new malls

Anarock says institutional investors now hold stakes in over 30% of malls, with upcoming Grade A launches and GST reforms driving new retail-focused REIT activity

Madhya Pradesh, Rajasthan probe child deaths linked to cough syrup

Drug authorities in Madhya Pradesh and Rajasthan are probing child deaths linked to cough syrup supplied to government hospitals, with testing of samples and quality concerns

Govt invites proposals under PRIP scheme for pharma, medtech projects

DoP recently notified revised guidelines to make scheme better suited for stakeholders